Dosage form
Solution for injection 5 ml №5.

Active ingredient
1 ml of solution contains 100 mg of tranexamic acid on a 100% substance basis.

Indications
Bleeding or risk of bleeding risk with increasing fibrinolysis both generalized (bleeding during surgery and in the postoperative period, postpartum haemorrhage, manual separation of placenta, placental chorionic, bleeding during pregnancy, malignancy, pancreatic and prostate cancer, haemophilia, haemorrhagic complications in fibrinolytic therapy, thrombocytopenic purpura, leukaemia, liver diseases, previous therapy with streptokinase) and local (uterine, nasal, pulmonary, gastrointestinal bleeding, haematuria, bleeding after prostatectomy, cervical conisation due to carcinoma, tooth extraction in patients with haemorrhagic diathesis). Surgeries on the bladder. Surgical manipulations in systemic inflammatory response (sepsis, peritonitis, necrotizing pancreatitis, severe and moderate gestational toxicosis, shock of different aethiology and other critical states).